Cardlytics, Inc. (NASDAQ:CDLX) Receives Consensus Rating of “Hold” from Brokerages

Shares of Cardlytics, Inc. (NASDAQ:CDLXGet Free Report) have been given a consensus rating of “Hold” by the seven ratings firms that are covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, five have given a hold rating and one has given a strong buy rating to the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $6.92.

Several brokerages have issued reports on CDLX. Evercore ISI started coverage on shares of Cardlytics in a research note on Friday, October 11th. They issued an “in-line” rating and a $4.00 price target on the stock. Needham & Company LLC restated a “hold” rating on shares of Cardlytics in a report on Friday, January 17th. Finally, Craig Hallum upgraded Cardlytics from a “hold” rating to a “strong-buy” rating in a report on Wednesday, November 6th.

Get Our Latest Research Report on CDLX

Cardlytics Stock Down 8.1 %

CDLX stock opened at $3.16 on Thursday. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.18 and a quick ratio of 1.18. The stock has a market capitalization of $160.60 million, a P/E ratio of -0.52 and a beta of 1.53. Cardlytics has a fifty-two week low of $2.76 and a fifty-two week high of $20.52. The business has a 50-day moving average of $3.65 and a 200-day moving average of $4.27.

Cardlytics (NASDAQ:CDLXGet Free Report) last released its quarterly earnings results on Wednesday, November 6th. The company reported ($0.15) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.33) by $0.18. Cardlytics had a negative return on equity of 110.67% and a negative net margin of 93.55%. The firm had revenue of $67.06 million during the quarter, compared to the consensus estimate of $57.77 million. During the same quarter in the prior year, the firm posted ($0.26) EPS. The business’s revenue was down 15.1% on a year-over-year basis. On average, sell-side analysts anticipate that Cardlytics will post -1.52 earnings per share for the current fiscal year.

Insider Activity

In related news, CEO Amit Gupta sold 15,160 shares of the business’s stock in a transaction that occurred on Friday, January 24th. The stock was sold at an average price of $3.92, for a total transaction of $59,427.20. Following the transaction, the chief executive officer now directly owns 215,494 shares of the company’s stock, valued at approximately $844,736.48. The trade was a 6.57 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Alexis Desieno sold 25,118 shares of the firm’s stock in a transaction on Friday, November 15th. The shares were sold at an average price of $3.43, for a total value of $86,154.74. Following the sale, the chief financial officer now directly owns 116,481 shares of the company’s stock, valued at $399,529.83. This represents a 17.74 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 61,560 shares of company stock valued at $223,687. 4.40% of the stock is owned by company insiders.

Institutional Trading of Cardlytics

Hedge funds have recently modified their holdings of the stock. Tallon Kerry Patrick bought a new position in Cardlytics in the 4th quarter valued at about $37,000. Atom Investors LP acquired a new position in shares of Cardlytics in the third quarter valued at approximately $33,000. XTX Topco Ltd bought a new position in shares of Cardlytics during the second quarter worth approximately $107,000. SG Americas Securities LLC acquired a new stake in Cardlytics during the 3rd quarter worth approximately $45,000. Finally, Intech Investment Management LLC acquired a new stake in Cardlytics during the 3rd quarter worth approximately $47,000. Institutional investors and hedge funds own 68.10% of the company’s stock.

About Cardlytics

(Get Free Report

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

See Also

Analyst Recommendations for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.